Showing results (91-100 of 398) with videos related to

Sort By:
Pageof 40
Cancer Research and Treatment|November 19, 2016
A Randomized Phase II Study of Leucovorin/5-Fluorouracil with or without Oxaliplatin (LV5FU2 vs. FOLFOX) for Curatively-Resected, Node-Positive Esophageal Squamous Cell CarcinomaSung Hee Lim, Young Mog Shim, Se Hoon Park, et al.
Oncotarget|November 2, 2017
The impact of pathologic differentiation (well/poorly) and the degree of Ki-67 index in patients with metastatic WHO grade 3 GEP-NECsHee Kyung Kim, Sang Yun Ha, Jeeyun Lee, et al.
Plos One|April 5, 2013
Supplementation of Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032 in diet-induced obese mice is associated with gut microbial changes and reduction in obesityDo-Young Park, Young-Tae Ahn, Se-Hoon Park, et al.
Cancer Research and Treatment|August 22, 2014
Changes in the mean corpuscular volume after capecitabine treatment are associated with clinical response and survival in patients with advanced gastric cancerHyun Ae Jung, Hyun-Jun Kim, Chi Hoon Maeng, et al.
Translational Oncology|February 16, 2018
The Correlation Between Serum Chemokines and Clinical Outcome in Patients with Advanced Biliary Tract CancerSu Jin Lee, Jung Eun Kim, Seung Tae Kim, et al.
Cancer Medicine|September 20, 2021
Reducing tumor invasiveness by ramucirumab and TGF-β receptor kinase inhibitor in a diffuse-type gastric cancer patient-derived cell modelSong-Yi Lee, Seonggyu Byeon, Jihoon Ko, et al.
Journal of Cancer|June 18, 2019
The Impact of Primary Tumor Sidedness on the Effect of Regorafenib in Refractory Metastatic Colorectal CancerSang Eun Yoon, Su Jin Lee, Jeeyun Lee, et al.
Oncotargets and Therapy|January 15, 2019
The use of regorafenib for patients with refractory metastatic colorectal cancer in clinical practiceSang Eun Yoon, Su Jin Lee, Jeeyun Lee, et al.
Journal of Microbiology and Biotechnology|October 10, 2013
Lactobacillus plantarum HY7712 protects against the impairment of NK-cell activity caused by whole-body γ-irradiation in miceHoyong Lee, Young-Tae Ahn, Se-Hoon Park, et al.
Anti-Cancer Drugs|May 31, 2008
Mitomycin C plus S-1 as second-line therapy in patients with advanced gastric cancer: a noncomparative phase II studySe Hoon Park, Young Saing Kim, Junshik Hong, et al.
Pageof 40